Discontinued — last reported Q4 '25
Insmed Other Comprehensive Income (Loss) increased by 49.8% to -$165.02M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.3%, from -$255.20M to -$165.02M. Over 4 years (FY 2021 to FY 2025), Other Comprehensive Income (Loss) shows a downward trend with a 30.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A large positive value suggests favorable currency or market movements, while a large negative value indicates potential future volatility in equity.
This represents the aggregate of all items of other comprehensive income or loss, which are excluded from net income und...
Standardized across all public companies under GAAP/IFRS reporting requirements.
tmusz_other_comprehensive_income_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$116.99M | -$113.04M | -$112.11M | -$95.82M | -$96.34M | -$131.60M | -$157.98M | -$159.44M | -$247.14M | -$159.76M | -$184.73M | -$157.98M | -$301.80M | -$217.15M | -$238.38M | -$255.20M | -$319.05M | -$369.76M | -$329.02M | -$165.02M |
| QoQ Change | — | +3.4% | +0.8% | +14.5% | -0.5% | -36.6% | -20.0% | -0.9% | -55.0% | +35.4% | -15.6% | +14.5% | -91.0% | +28.1% | -9.8% | -7.1% | -25.0% | -15.9% | +11.0% | +49.8% |
| YoY Change | — | — | — | — | +17.6% | -16.4% | -40.9% | -66.4% | -156.5% | -21.4% | -16.9% | +0.9% | -22.1% | -35.9% | -29.0% | -61.5% | -5.7% | -70.3% | -38.0% | +35.3% |